China Resources Pharmaceutical Group Ltd. (HK:3320) has released an update.
China Resources Pharmaceutical Group Ltd. has announced the continuation of its energy purchase transactions with CR Gas Chenzhou, securing energy supplies for its Southern China manufacturing center until the end of 2025. These transactions are in compliance with the Hong Kong Stock Exchange’s listing rules and will only require regular reporting and review, without the need for independent shareholder approval. The agreement reinforces the company’s commitment to uninterrupted energy provision for heating, cooling, and electricity needs.
For further insights into HK:3320 stock, check out TipRanks’ Stock Analysis page.
